Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growth

This publication has 13 references indexed in Scilit:

• Determinants of Prostate Cancer–Specific Survival After Radiation Therapy for Patients With Clinically Localized Prostate Cancer
  Journal of Clinical Oncology, 2002
• Short term androgen deprivation and PSA doubling time: their relationship to one another and to disease progression following radiation therapy for prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Lack of prostate cancer radiosensitization by androgen deprivation
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
  International Journal of Radiation Oncology*Biology*Physics, 2001
• The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions
  International Journal of Radiation Oncology*Biology*Physics, 2000
• After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
  Urological Research, 1999
• Natural History of Progression After PSA Elevation Following Radical Prostatectomy
  JAMA, 1999
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997